Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethane SCHEMBL2815456 | 0.96 | ALDH1A1 (0.32) | ALDH1A1MEN1KMT2A | |
| SCHEMBL1335532 | 0.94 | — | — | |
| Propane SCHEMBL6761944 | 0.94 | MEN1 (0.35) | TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL5145542 | 0.91 | SMN1; SMN2 (0.37) | TSHRSMN1; SMN2MAPTALDH1A1MEN1 | |
| SCHEMBL13042486 | 0.91 | SMN1; SMN2 (0.41) | TSHRSMN1; SMN2MAPTALDH1A1MAPK1 | |
| SCHEMBL17617949 | 0.90 | — | — | |
| SCHEMBL13042487 | 0.90 | SMN1; SMN2 (0.45) | TSHRSMN1; SMN2MAPTALDH1A1MAPK1 | |
| SCHEMBL28452262 | 0.88 | ALDH1A1 (0.34) | TSHRSMN1; SMN2ALDH1A1 | |
| SCHEMBL20233447 | 0.87 | — | — | |
| SCHEMBL28065030 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1675 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115368056-A | Crystal nucleus enhanced liquid alkali-free accelerator and preparation method and application thereof | 河北三楷深发科技股份有限公司 | 2022-11-22 | — | — | CN | claimed |
| CN-115368514-A | Dispersing agent for crystal nucleus type early strength agent, crystal nucleus type early strength agent and preparation method | 河北三楷深发科技股份有限公司 | 2022-11-22 | — | — | CN | claimed |
| US-11197887-B2 | Proton-binding polymers for oral administration | TRICIDA, INC. (US) | 2021-12-14 | — | — | US | claimed |
| EP-3219312-B1 | ION BINDING POLYMERS AND USES THEREOF | RELYPSA INC (US) | 2019-01-30 | — | — | EP | claimed |
| EP-3219312-A1 | ION BINDING POLYMERS AND USES THEREOF | Relypsa, Inc. (US) | 2017-09-20 | — | — | EP | claimed |
| US-8889115-B2 | Ion binding polymers and uses thereof | RELYPSA, INC. (US) | 2014-11-18 | — | — | US | claimed |
| US-20140286891-A1 | ION BINDING POLYMERS AND USES THEREOF | ILYPSA, INC. | 2014-09-25 | — | — | US | claimed |
| US-8778324-B2 | Ion binding polymers and uses thereof | RELYPSA, INC. (US) | 2014-07-15 | — | — | US | claimed |
| EP-2269589-B1 | Ion binding polymers and uses thereof | RELYPSA INC (US) | 2013-12-25 | — | — | EP | claimed |
| US-20130272991-A1 | ION BINDING POLYMERS AND USES THEREOF | VIFOR (INTERNATIONAL) LTD. (CH) | 2013-10-17 | — | — | US | claimed |
| EP-0736801-B1 | Molecular grafting to energetically treated polyesters to promote adhesion of gelatin-containing layers | EASTMAN KODAK CO (US) | 2004-02-18 | — | — | EP | claimed |
| US-20030186811-A1 | Recording material | FUJI PHOTO FILM CO., LTD. | 2003-10-02 | — | — | US | claimed |
| EP-0785466-B1 | Molecular grafting of hardener/gelatin blends to energetically treated polyesters to promote adhesion of layers | EASTMAN KODAK CO (US) | 2003-09-03 | — | — | EP | claimed |
| EP-0929530-B1 | QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ASTRAZENECA AB (SE) | 2002-11-20 | — | — | EP | claimed |
| US-5968646-A | Molecular grafting of hardener/gelatin blends to energetically treated polyesters to promote adhesion of layers | EASTMAN KODAK COMPANY (US) | 1999-10-19 | — | — | US | claimed |
| US-5700577-A | Molecular grafting to energetically treated polyesters to promote adhesion of gelatin-containing layers | EASTMAN KODAK COMPANY (US) | 1997-12-23 | — | — | US | claimed |
| EP-0785466-A1 | Molecular grafting of hardener/gelatin blends to energetically treated polyesters to promote adhesion of layers | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1997-07-23 | — | — | EP | claimed |
| EP-0736801-A2 | Molecular grafting to energetically treated polyesters to promote adhesion of gelatin-containing layers | EASTMAN KODAK COMPANY (US) | 1996-10-09 | — | — | EP | claimed |
| US-5563029-A | COATING TREATED SURFACE WITH A DILUTE AMINE REACTIVE HARDENER SOLUTION; DRYING; APPLYING PHOTOGRAPHIC EMULSION | EASTMAN KODAK COMPANY (US) | 1996-10-08 | — | — | US | claimed |
| US-4568635-A | TETRASUBSTITUTED THIOUREA AS SOLVENT AND VINYL-SULFONYL CONTAING COMPOUND AS HARDENER | FUJI PHOTO FILM CO., LTD. (JP) | 1986-02-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130272991-A1 | ION BINDING POLYMERS AND USES THEREOF | ATP6V1B1, KCNN3, SLC9A3 | TSHR 3454/4885SMN1; SMN2 4527/4885MAPT 3379/4885 |
| US-20140286891-A1 | ION BINDING POLYMERS AND USES THEREOF | ATP6V1B1, KCNN3, SLC9A3 | TSHR 3454/4885SMN1; SMN2 4527/4885MAPT 3379/4885 |
| US-11197887-B2 | Proton-binding polymers for oral administration | SLC9A1, HRH2, SLC9A2 | TSHR 1639/4885SMN1; SMN2 1911/4885MAPT 3207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.